Nalaganje...
Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro.
Doxorubicin (Dox) is an anthracycline antibiotic for cancer therapy with limited usage due to cardiotoxicity. Isorhamnetin is a nature antioxidant with obvious cardiac protective effect. The aim of this study is going to investigate the possible protective effect of isorhamnetin against Dox-induced...
Shranjeno v:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Public Library of Science (PLoS)
2013-01-01
|
Serija: | PLoS ONE |
Online dostop: | http://europepmc.org/articles/PMC3665796?pdf=render |
Oznake: |
Označite
Brez oznak, prvi označite!
|